EP1152711B1 - Bifurcation stent delivery system - Google Patents

Bifurcation stent delivery system Download PDF

Info

Publication number
EP1152711B1
EP1152711B1 EP00905738A EP00905738A EP1152711B1 EP 1152711 B1 EP1152711 B1 EP 1152711B1 EP 00905738 A EP00905738 A EP 00905738A EP 00905738 A EP00905738 A EP 00905738A EP 1152711 B1 EP1152711 B1 EP 1152711B1
Authority
EP
European Patent Office
Prior art keywords
balloon
stent
catheter
distal
bifurcation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP00905738A
Other languages
German (de)
French (fr)
Other versions
EP1152711A1 (en
Inventor
Tracee E. J. Eidenschink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Boston Scientific Ltd Barbados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Ltd Barbados filed Critical Boston Scientific Ltd Barbados
Priority to EP05005600A priority Critical patent/EP1547546B1/en
Publication of EP1152711A1 publication Critical patent/EP1152711A1/en
Application granted granted Critical
Publication of EP1152711B1 publication Critical patent/EP1152711B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/954Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • A61F2002/067Y-shaped blood vessels modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1045Balloon catheters with special features or adapted for special applications for treating bifurcations, e.g. balloons in y-configuration, separate balloons or special features of the catheter for treating bifurcations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape

Definitions

  • the present invention relates to a system for treating vascular disease. More specifically, the present invention relates to a system for deploying a stent in a bifurcation lesion.
  • vascular disease currently represents a prevalent medical condition. Typical vascular disease involves the development of a stenosis in the vasculature. The particular vessel containing the stenosis can be completely blocked (or occluded) or it can simply be narrowed (or restricted). In either case, restriction of the vessel caused by the stenotic lesion results in many well known problems caused by the reduction or cessation of blood circulation through the restricted vessel.
  • a bifurcation is an area of the vasculature where a first (or parent) vessel is bifurcated into two or more branch vessels. It is not uncommon for stenotic lesions to form in such bifurcations. The stenotic lesions can affect only one of the vessels (i.e., either of the branch vessels or the parent vessel) two of the vessels, or all three vessels.
  • Vascular stents are also currently well known.
  • Vascular stents typically involve a tubular stent which is movable from a collapsed, low profile, delivery position to an expanded, deployed position.
  • the stent is typically delivered using a stent delivery device, such as a stent delivery catheter.
  • the stent is crimped down to its delivery position over an expandable element, such as a stent deployment balloon.
  • the stent is then advanced using the catheter attached to the stent deployment balloon to the lesion site under any suitable, commonly known visualization technique.
  • the balloon is then expanded to drive the stent from its delivery position to its deployed position in which the outer periphery of the stent frictionally engages the inner periphery of the lumen.
  • the lumen is predilated using a conventional dilatation catheter, and then the stent is deployed to maintain the vessel in an unoccluded, and unrestricted position.
  • Self-expanding stents can also be used.
  • Self-expanding stents are typically formed of a resilient material.
  • the resilient material has sufficient resilience that it can be collapsed to the low profile position and inserted within a delivery device, such as a catheter. Once the catheter is placed at the site of the stenotic lesion, the stent is pushed from within the catheter such that it is no longer constrained in its low profile position.
  • the stent driven by the resilience of the material, expands to a higher profile, deployed position in which its outer periphery frictionally engages the walls of the stenosed vessel, thereby reducing the restriction in the vessel.
  • the treating physician must then advance a dilatation balloon between the struts of the stent already deployed in order to dilate the second branch vessel.
  • the physician may then attempt to maneuver a second stent through the struts of the stent already deployed, into the second branch vessel for deployment.
  • This presents significant difficulties For example, dilating between the struts of the stent already deployed tends to distort that stent.
  • deploying the second stent through the struts of the first stent is not only difficult, but it can also distort the first stent.
  • the current systems used to alternately deploy stents in a bifurcated lesion have significant disadvantages.
  • branch vessels can have somewhat smaller diameter lumens than the parent vessels from which they branch. Therefore, stents of different sizes need to be deployed in the parent vessel and the branch vessel.
  • a single stent having a larger diameter portion, and one or more smaller diameter portions can be deployed at the bifurcation.
  • this can lead to difficulty in deployment.
  • a balloon which is sized to fit within the smaller diameter stent portion, and deploy that portion may not be large enough to deploy the larger diameter stent portion. Therefore, a plurality of balloon catheters must be used to deploy such stents.
  • US 5 749 825 shows an alternative solution to this problem, where one balloon with a larger diameter is used to dilate the parent vessel and one branch of a bifurcation simultaneously.
  • the present invention is drawn to a system for deploying a stent at a bifurcation.
  • the present invention is a dual balloon stent deployment catheter.
  • FIG. 1 illustrates bifurcation 10 which includes parent vessel 12, first branch vessel 14 and second branch vessel 16.
  • FIG. 1 also illustrates that a bifurcation lesion 18 has developed in bifurcation 10.
  • lesion 18 extends into both branch vessels 14 and 16, and extends slightly into parent vessel 12 as well.
  • Lesion 18 may also be located on only one side of the branch vessel 14 or 16. In either case, it is preferable to stent both branch vessels 14 and 16 to avoid collapsing one.
  • it may commonly first be predilated with a conventional angioplasty balloon catheter dilatation device.
  • FIG. 2 is a side view of a stent 20 which can be used to treat a portion of bifurcation 10.
  • Stent 20 includes a first portion 22 and a second portion 24.
  • First portion 22 has a relatively large deployed diameter, while second portion 24 has a somewhat smaller deployed diameter.
  • FIG. 3 is an end view of stent 20 taken as indicated by arrows 3-3 in FIG. 2.
  • portions 22 and 24 of stent 20 are simply discrete stents which have been interwoven, or attached, to one another.
  • stent 20 can be formed by one integral stent formed with portions 22 and 24 being integral with one another.
  • stent 20 can preferably be deformed to a low profile, collapsed (or deployment) position in which it can be inserted through parent vessel 12 to bifurcation 10. Stent 20 is then deployed, either using its own resilience, or using a balloon deployment system, to its expanded, deployed position illustrated in FIG. 2.
  • FIG. 4 illustrates stent 20 deployed in bifurcation 10.
  • first and second guidewires 26 and 28 are first inserted, through parent vessel 12, to bifurcation 10 such that guidewire 26 has a distal end residing in branch vessel 14 while guidewire 28 has a distal end residing in branch vessel 16.
  • stent 20 is advanced in a low profile, insertion position to the location illustrated in FIG. 4.
  • Stent 20 is then deployed by expanding portions 22 and 24 to the deployed positions illustrated in FIG. 4.
  • portion 24 has an outer diameter which, when deployed, frictionally engages the inner diameter of branch vessel 14.
  • portion 22 has an outer diameter which, when deployed, is sufficient to frictionally engage the inner diameter of parent vessel 12, to remain in place in bifurcation 10.
  • FIG. 5 is a side view of a dual-balloon stent deployment system 30 in accordance with the present invention.
  • System 30 is shown with a cross-section of stent 20, in the deployed position, disposed thereon.
  • System 30 includes a proximal catheter 32 having a lumen 34 disposed therein.
  • First and second guidewire lumens (or tubes) 36 and 38 extend from within lumen 34 and extend to distal ends 40 and 42.
  • System 30 also includes a first, proximal balloon 44 and a second, distal balloon 46.
  • Balloon 44 has a proximal end 48 which is sealed to the distal end of catheter 32. While proximal end 48 of balloon 44 can be sealed to either the outer or inner side of catheter 32, it is illustrated in FIG.
  • Balloon 44 also has a distal end 50 which is sealed, with a fluid tight seal, about guidewire tube 36 and a portion of the proximal end 52 of balloon 46.
  • Balloon 46 includes a proximal end 52 which is also fluidly sealed partially to an inside surface of the distal waist of balloon 44 and partially to guidewire lumen 38. However, an inflation lumen 54 extends from the interior of balloon 44, through the proximal end 52 of balloon 46, and communicates with the interior or balloon 46. Balloon 46 further includes a distal end 56 which is sealed to the outer surface of guidewire lumen 42. Therefore, an inflation lumen for inflating balloons 44 and 46 is defined by lumen 34 of catheter 42, and lumen 54 disposed about at least a portion of guidewire tubes 36 and 38.
  • Guidewire lumen 38 extends from lumen 34 distally through both balloons 44 and 46, and protrudes out the distal end 56 of balloon 46.
  • Guidewire lumen 36 is used to track a guidewire which extends down a branching vessel.
  • Guidewire lumen 38 has a distal end 40 which extends out from within the distal end 50 of balloon 44, and extends to a position outside of balloon 46. Both balloons 44 and 46 can preferably be-collapsed to a low profile, insertion position.
  • balloon 44 has a relatively large inflated diameter for driving deployment of the larger diameter portion 22 of stent 20.
  • Balloon 46 on the other hand, has a smaller inflated diameter for driving deployment of the smaller diameter stent portion 24 of stent 20.
  • FIGS. 6A and 6B illustrate the deployment of stent 20 utilizing system 30 illustrated in FIG. 5.
  • FIG. 6A illustrates system 30 in the insertion position.
  • guidewires 26 and 28 are advanced through the vasculature to bifurcation 10, such that they reside within branch vessels 14 and 16, pespectively.
  • system 30 can be backloaded onto guidewires 26 and 28.
  • system 30 prior to inserting guidewires 26 and 28, system 30 is loaded onto the guidewire such that guidewire 26 resides within guidewire tube 38 while guidewire 28 resides within tube 30.
  • system 30 can be loaded onto guidewires 26 and 28 from the proximal end of the guidewires.
  • system 30 is advanced using catheter 32 through the vasculature (and may be advanced through a guide catheter 58) to bifurcation 10. System 30 is then further advanced such that stent portion 24 follows guidewire 26 and resides within branch vessel 14.
  • fluid is introduced into balloons 44 and 46 through catheter 32, to inflate the balloons.
  • This drives stent portions 22 and 24 of stent 20 into the deployed position illustrated in FIG. 6B.
  • the outer diameter of stent portions 22 and 24 are sufficient to frictionally engage the interior vessel walls of parent vessel 12 and branch vessel 14, respectively, such that stent 20 is frictionally held in place in bifurcation 10.
  • the lumens 44 and 46 are then deflated, and system 30 is removed from within stent 20.
  • Guidewires 26 and 28 are then removed from bifurcation 10, leaving stent 20 deployed in place.
  • System 30 preferably employs balloons 44 and 46 which have steep proximal and distal cone angles in order to reduce any gap between the balloons, this increases the ability to exert adequate deployment force on stent portions 22 and 24.
  • post delivery dilatation may be used in order to further dilate the lesion from within the deployed stent 20.
  • FIG. 7 illustrates a side view of another embodiment of a dual-balloon stent deployment system 60 in accordance with one aspect of the present invention.
  • System 60 has a number of items which are similar to system 30 shown in FIG. 5, and those items are similarly numbered in FIG. 7.
  • System 60 includes a proximal balloon 62 which has a proximal end 64 and a distal end 66.
  • the proximal end 64 in balloon 62 is sealed about the distal end of catheter 32.
  • the interior of balloon 62 communicates with lumen 34 of catheter 32.
  • the distal end 66 of balloon 62 is formed in a cone configuration.
  • a radially interior portion is sealed about guidewire tubes 36 and 38, leaving an inflation lumen 68 therebetween, which communicates with the interior of balloon 46.
  • the radial outward portion of the distal end 66 of balloon 62 when inflated, assumes an outer diameter which is substantially the same as the maximum diameter of the remainder of balloon 62. However, the distal end 66 is formed in a reverse cone shape such that the radial outward portion of the distal end 66 is substantially tubular in shape.
  • the balloon tapers proximally along a portion 70 to the inner diameter portion of balloon 62.
  • the outer diameter of balloon 62 obtains a substantially greater size, at its extreme distal end, than balloon 44 in system 30. This assists in deploying portion 22 of stent 20.
  • post-delivery dilatation may be used to further advance stent portions 22 and 24 toward the wall of vessels 12 and 14, respectively.
  • Stent deployment system 60 is deployed in a similar fashion as stent deployment system 30, illustrated with respect to FIGS. 6A and 6B.
  • FIGS. 8A and 8B illustrate a problem which can be encountered in deploying a stent in a bifurcation.
  • FIG. 8A illustrates a stent deployment system 72 located just proximally of bifurcation 10.
  • Stent deployment system 72 includes a distal stent portion 74 which has a distal end 76.
  • FIG. 8A also illustrates that guidewires 26 and 28 are crossed over one another in a cross-over region 78. As deployment system 72 is advanced distally, the distal end 76 of stent portion 74 encounters cross over region 78.
  • FIG. 8B illustrates that the distal end 76 of stent portion 74 can actually catch, and hang up on, a portion of guidewire 28 which is crossed over guidewire 26.
  • FIG. 9A illustrates stent deployment system 60, as discussed with respect to FIG. 7, but with the addition of a distal sleeve 80 or a proximal sleeve 82 or both disposed about the distal end of stent portion 24 and the proximal end of stent portion 22, respectively.
  • Distal sleeve 80 and proximal sleeve 82 are provided in order to minimize the likelihood that the longitudinal ends of stent 20 will catch or engage any unwanted obstacles, such as tissue or guidewires.
  • the siteves 80 and 82 are described in greater detail in U.S. Patent No. 4,950,227. Briefly, sleeves 80 and 82 are illustratively formed of silicone and are approximately 2 cm in length.
  • Sleeve 80 is fixed to the distal end 42 of guidewire lumen 38 using adhesive or welding.
  • the proximal end of sleeve 82 is fixed to the distal end of catheter 32, using a suitable adhesive.
  • adhesive may, for example, be comprised of a urethane bead.
  • Sleeves 80 and 82 overlap stent portions 24 and 22, respectively, by a distance which is approximately 3 mm.
  • sleeves 80 and 82 have tapered distal edges.
  • sleeves 80 and 82 have tapered distal and proximal edges. This facilitates the transfer of system 60 within the vasculature, while decreasing the tendency to catch or engage undesired obstacles.
  • FIGS. 9B and 9C illustrate the deployment of stent portion 24 and the interaction of stent portion 24 with sleeve 80.
  • a similar interaction is obtained between sleeve 82 and the proximal end of stent portion 22.
  • balloon 46 is inflated and the distal end of stent portion 24 is released from within sleeve 80. This is illustrated in FIG. 9B. Then, after stent portion 24 is deployed and balloon 46 is deflated (and thus radially retracted) sleeve 80 contracts about the distal end of balloon 46.
  • balloon 46 facilitates removal of balloon 46, as well as sleeve 80, from within the deployed stent portion 24, as deployment system 60 is axially removed from the vasculature.
  • sleeves 80 and 82 can be used on substantially any of the embodiments described herein.
  • the present invention provides a system for deploying a stent at a bifurcation.
  • the system includes a variety of dual-balloon delivery and deployment systems.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is drawn to a system and/or device for deploying a stent at a bifurcation. In one embodiment, the system and/or device for deploying a stent at a bifurcation may include a dual balloon catheter may include an elongate catheter body. Some dual balloon catheters may have a first proximal balloon and a second balloon bonded to at least a portion of the elongate catheter body. In some cases, a guide wire port may be positioned between the first and second balloons.

Description

    BACKGROUND OF THE INVENTION
  • The present invention relates to a system for treating vascular disease. More specifically, the present invention relates to a system for deploying a stent in a bifurcation lesion.
  • Vascular disease currently represents a prevalent medical condition. Typical vascular disease involves the development of a stenosis in the vasculature. The particular vessel containing the stenosis can be completely blocked (or occluded) or it can simply be narrowed (or restricted). In either case, restriction of the vessel caused by the stenotic lesion results in many well known problems caused by the reduction or cessation of blood circulation through the restricted vessel.
  • A bifurcation is an area of the vasculature where a first (or parent) vessel is bifurcated into two or more branch vessels. It is not uncommon for stenotic lesions to form in such bifurcations. The stenotic lesions can affect only one of the vessels (i.e., either of the branch vessels or the parent vessel) two of the vessels, or all three vessels.
  • Vascular stents are also currently well known. Vascular stents typically involve a tubular stent which is movable from a collapsed, low profile, delivery position to an expanded, deployed position. The stent is typically delivered using a stent delivery device, such as a stent delivery catheter. In one common technique, the stent is crimped down to its delivery position over an expandable element, such as a stent deployment balloon. The stent is then advanced using the catheter attached to the stent deployment balloon to the lesion site under any suitable, commonly known visualization technique. The balloon is then expanded to drive the stent from its delivery position to its deployed position in which the outer periphery of the stent frictionally engages the inner periphery of the lumen. In some instances, the lumen is predilated using a conventional dilatation catheter, and then the stent is deployed to maintain the vessel in an unoccluded, and unrestricted position.
  • Self-expanding stents can also be used. Self-expanding stents are typically formed of a resilient material. The resilient material has sufficient resilience that it can be collapsed to the low profile position and inserted within a delivery device, such as a catheter. Once the catheter is placed at the site of the stenotic lesion, the stent is pushed from within the catheter such that it is no longer constrained in its low profile position. The stent, driven by the resilience of the material, expands to a higher profile, deployed position in which its outer periphery frictionally engages the walls of the stenosed vessel, thereby reducing the restriction in the vessel.
  • While there have recently been considerable advances in stent design and stent deployment techniques, current methods of treating bifurcation lesions are suboptimal, particularly where both downstream branch vessels are affected by the lesion. Current techniques of dealing with such lesions typically require the deployment of a slotted tube stent across the bifurcation. However, this compromises the ostium of the unstented branch.
  • Further, once the first stent is deployed, the treating physician must then advance a dilatation balloon between the struts of the stent already deployed in order to dilate the second branch vessel. The physician may then attempt to maneuver a second stent through the struts of the stent already deployed, into the second branch vessel for deployment. This presents significant difficulties. For example, dilating between the struts of the stent already deployed tends to distort that stent. Further, deploying the second stent through the struts of the first stent is not only difficult, but it can also distort the first stent. Thus, the current systems used to alternately deploy stents in a bifurcated lesion have significant disadvantages.
  • Also, since two guidewires are often used to deploy stents at a bifurcation, the guidewires can become crossed, or somewhat entangled. The deployment systems which are advanced along such guidewires can become caught on the wires, where they cross over one another. This can require additional time and manipulation of the stent deployment system in order to properly deploy the stent at the bifurcation.
  • Further, some branch vessels can have somewhat smaller diameter lumens than the parent vessels from which they branch. Therefore, stents of different sizes need to be deployed in the parent vessel and the branch vessel. Alternatively, a single stent having a larger diameter portion, and one or more smaller diameter portions, can be deployed at the bifurcation. However, this can lead to difficulty in deployment. For instance, a balloon which is sized to fit within the smaller diameter stent portion, and deploy that portion, may not be large enough to deploy the larger diameter stent portion. Therefore, a plurality of balloon catheters must be used to deploy such stents. US 5 749 825 shows an alternative solution to this problem, where one balloon with a larger diameter is used to dilate the parent vessel and one branch of a bifurcation simultaneously.
  • SUMMARY OF THE INVENTION
  • The present invention is drawn to a system for deploying a stent at a bifurcation.
  • The present invention is a dual balloon stent deployment catheter.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates a typical bifurcation lesion.
  • FIGS. 2 and 3 illustrate a stent having two different deployed diameters.
  • FIG. 4 illustrates the stent shown in FIGS. 2 and 3 deployed in a bifurcation.
  • FIG. 5 illustrates a dual-balloon stent deployment system.
  • FIGS. 6A and 6B illustrate deployment of the stent deployment system illustrated in FIG. 5.
  • FIG. 7 illustrates another embodiment of a dual-balloon stent deployment system.
  • FIGS. 8A and 8B illustrate catching of a distal portion of a stent deployment system on crossed or tangled guidewires.
  • FIGS. 9A-9C illustrate a stent deployment system with a distal sleeve disposed thereabout.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • FIG. 1 illustrates bifurcation 10 which includes parent vessel 12, first branch vessel 14 and second branch vessel 16. FIG. 1 also illustrates that a bifurcation lesion 18 has developed in bifurcation 10. As illustrated, lesion 18 extends into both branch vessels 14 and 16, and extends slightly into parent vessel 12 as well. Lesion 18 may also be located on only one side of the branch vessel 14 or 16. In either case, it is preferable to stent both branch vessels 14 and 16 to avoid collapsing one. In order to treat bifurcation lesion 18, it may commonly first be predilated with a conventional angioplasty balloon catheter dilatation device.
  • FIG. 2 is a side view of a stent 20 which can be used to treat a portion of bifurcation 10. Stent 20 includes a first portion 22 and a second portion 24. First portion 22 has a relatively large deployed diameter, while second portion 24 has a somewhat smaller deployed diameter.
  • FIG. 3 is an end view of stent 20 taken as indicated by arrows 3-3 in FIG. 2. In one illustrative embodiment, portions 22 and 24 of stent 20 are simply discrete stents which have been interwoven, or attached, to one another. Alternatively, stent 20 can be formed by one integral stent formed with portions 22 and 24 being integral with one another. In either case, stent 20 can preferably be deformed to a low profile, collapsed (or deployment) position in which it can be inserted through parent vessel 12 to bifurcation 10. Stent 20 is then deployed, either using its own resilience, or using a balloon deployment system, to its expanded, deployed position illustrated in FIG. 2.
  • FIG. 4 illustrates stent 20 deployed in bifurcation 10. In FIG. 4, first and second guidewires 26 and 28 are first inserted, through parent vessel 12, to bifurcation 10 such that guidewire 26 has a distal end residing in branch vessel 14 while guidewire 28 has a distal end residing in branch vessel 16. Using a stent deployment system, such as any of those described in greater detail later in the specification, stent 20 is advanced in a low profile, insertion position to the location illustrated in FIG. 4. Stent 20 is then deployed by expanding portions 22 and 24 to the deployed positions illustrated in FIG. 4. In one illustrative embodiment, portion 24 has an outer diameter which, when deployed, frictionally engages the inner diameter of branch vessel 14. Similarly, portion 22 has an outer diameter which, when deployed, is sufficient to frictionally engage the inner diameter of parent vessel 12, to remain in place in bifurcation 10.
  • FIG. 5 is a side view of a dual-balloon stent deployment system 30 in accordance with the present invention. System 30 is shown with a cross-section of stent 20, in the deployed position, disposed thereon. System 30 includes a proximal catheter 32 having a lumen 34 disposed therein. First and second guidewire lumens (or tubes) 36 and 38 extend from within lumen 34 and extend to distal ends 40 and 42. System 30 also includes a first, proximal balloon 44 and a second, distal balloon 46. Balloon 44 has a proximal end 48 which is sealed to the distal end of catheter 32. While proximal end 48 of balloon 44 can be sealed to either the outer or inner side of catheter 32, it is illustrated in FIG. 5 as being sealed to the outer surface of catheter 32, using, for example, an adhesive. Balloon 44 also has a distal end 50 which is sealed, with a fluid tight seal, about guidewire tube 36 and a portion of the proximal end 52 of balloon 46.
  • Balloon 46 includes a proximal end 52 which is also fluidly sealed partially to an inside surface of the distal waist of balloon 44 and partially to guidewire lumen 38. However, an inflation lumen 54 extends from the interior of balloon 44, through the proximal end 52 of balloon 46, and communicates with the interior or balloon 46. Balloon 46 further includes a distal end 56 which is sealed to the outer surface of guidewire lumen 42. Therefore, an inflation lumen for inflating balloons 44 and 46 is defined by lumen 34 of catheter 42, and lumen 54 disposed about at least a portion of guidewire tubes 36 and 38.
  • Guidewire lumen 38 extends from lumen 34 distally through both balloons 44 and 46, and protrudes out the distal end 56 of balloon 46. Guidewire lumen 36, on the other hand (and as will be disclosed in greater detail later in the specification) is used to track a guidewire which extends down a branching vessel. Guidewire lumen 38 has a distal end 40 which extends out from within the distal end 50 of balloon 44, and extends to a position outside of balloon 46. Both balloons 44 and 46 can preferably be-collapsed to a low profile, insertion position. However, balloon 44 has a relatively large inflated diameter for driving deployment of the larger diameter portion 22 of stent 20. Balloon 46, on the other hand, has a smaller inflated diameter for driving deployment of the smaller diameter stent portion 24 of stent 20.
  • FIGS. 6A and 6B illustrate the deployment of stent 20 utilizing system 30 illustrated in FIG. 5. FIG. 6A illustrates system 30 in the insertion position. First, guidewires 26 and 28 are advanced through the vasculature to bifurcation 10, such that they reside within branch vessels 14 and 16, pespectively. It should be noted that system 30 can be backloaded onto guidewires 26 and 28. In that case, prior to inserting guidewires 26 and 28, system 30 is loaded onto the guidewire such that guidewire 26 resides within guidewire tube 38 while guidewire 28 resides within tube 30. Alternatively, system 30 can be loaded onto guidewires 26 and 28 from the proximal end of the guidewires. In either case, after the guidewires are positioned appropriately, system 30 is advanced using catheter 32 through the vasculature (and may be advanced through a guide catheter 58) to bifurcation 10. System 30 is then further advanced such that stent portion 24 follows guidewire 26 and resides within branch vessel 14.
  • Once in the position illustrated in FIG. 6A, fluid is introduced into balloons 44 and 46 through catheter 32, to inflate the balloons. This drives stent portions 22 and 24 of stent 20 into the deployed position illustrated in FIG. 6B. In the deployed position, the outer diameter of stent portions 22 and 24 are sufficient to frictionally engage the interior vessel walls of parent vessel 12 and branch vessel 14, respectively, such that stent 20 is frictionally held in place in bifurcation 10. The lumens 44 and 46 are then deflated, and system 30 is removed from within stent 20. Guidewires 26 and 28 are then removed from bifurcation 10, leaving stent 20 deployed in place.
  • System 30 preferably employs balloons 44 and 46 which have steep proximal and distal cone angles in order to reduce any gap between the balloons, this increases the ability to exert adequate deployment force on stent portions 22 and 24. Similarly, post delivery dilatation may be used in order to further dilate the lesion from within the deployed stent 20.
  • FIG. 7 illustrates a side view of another embodiment of a dual-balloon stent deployment system 60 in accordance with one aspect of the present invention. System 60 has a number of items which are similar to system 30 shown in FIG. 5, and those items are similarly numbered in FIG. 7. System 60 includes a proximal balloon 62 which has a proximal end 64 and a distal end 66. The proximal end 64 in balloon 62 is sealed about the distal end of catheter 32. The interior of balloon 62 communicates with lumen 34 of catheter 32. The distal end 66 of balloon 62 is formed in a cone configuration. A radially interior portion is sealed about guidewire tubes 36 and 38, leaving an inflation lumen 68 therebetween, which communicates with the interior of balloon 46. The radial outward portion of the distal end 66 of balloon 62, when inflated, assumes an outer diameter which is substantially the same as the maximum diameter of the remainder of balloon 62. However, the distal end 66 is formed in a reverse cone shape such that the radial outward portion of the distal end 66 is substantially tubular in shape. The balloon tapers proximally along a portion 70 to the inner diameter portion of balloon 62.
  • In this way, the outer diameter of balloon 62 obtains a substantially greater size, at its extreme distal end, than balloon 44 in system 30. This assists in deploying portion 22 of stent 20. Again, post-delivery dilatation may be used to further advance stent portions 22 and 24 toward the wall of vessels 12 and 14, respectively. Stent deployment system 60 is deployed in a similar fashion as stent deployment system 30, illustrated with respect to FIGS. 6A and 6B.
  • FIGS. 8A and 8B illustrate a problem which can be encountered in deploying a stent in a bifurcation. FIG. 8A illustrates a stent deployment system 72 located just proximally of bifurcation 10. Stent deployment system 72 includes a distal stent portion 74 which has a distal end 76. FIG. 8A also illustrates that guidewires 26 and 28 are crossed over one another in a cross-over region 78. As deployment system 72 is advanced distally, the distal end 76 of stent portion 74 encounters cross over region 78. FIG. 8B illustrates that the distal end 76 of stent portion 74 can actually catch, and hang up on, a portion of guidewire 28 which is crossed over guidewire 26. This makes it very difficult, if not impossible, to continue to advance stent deployment system 72 distally over guidewires 26 and 28. Instead, system 72 must be withdrawn proximally, and the guidewires 26 and 28 must be remanipulated or deployment system 72 must be torqued (rotated about its longitudinal axis) or otherwise maneuvered, in an attempt to loosen guidewire 28 from the distal end 76 of stent portion 74.
  • FIG. 9A illustrates stent deployment system 60, as discussed with respect to FIG. 7, but with the addition of a distal sleeve 80 or a proximal sleeve 82 or both disposed about the distal end of stent portion 24 and the proximal end of stent portion 22, respectively. Distal sleeve 80 and proximal sleeve 82 are provided in order to minimize the likelihood that the longitudinal ends of stent 20 will catch or engage any unwanted obstacles, such as tissue or guidewires. The siteves 80 and 82 are described in greater detail in U.S. Patent No. 4,950,227. Briefly, sleeves 80 and 82 are illustratively formed of silicone and are approximately 2 cm in length. Sleeve 80 is fixed to the distal end 42 of guidewire lumen 38 using adhesive or welding. Similarly, the proximal end of sleeve 82 is fixed to the distal end of catheter 32, using a suitable adhesive. Such adhesive may, for example, be comprised of a urethane bead. Sleeves 80 and 82 overlap stent portions 24 and 22, respectively, by a distance which is approximately 3 mm. Further, in one embodiment, sleeves 80 and 82 have tapered distal edges. In a further embodiment, sleeves 80 and 82 have tapered distal and proximal edges. This facilitates the transfer of system 60 within the vasculature, while decreasing the tendency to catch or engage undesired obstacles.
  • FIGS. 9B and 9C illustrate the deployment of stent portion 24 and the interaction of stent portion 24 with sleeve 80. A similar interaction is obtained between sleeve 82 and the proximal end of stent portion 22. As stent portion 24 is deployed, balloon 46 is inflated and the distal end of stent portion 24 is released from within sleeve 80. This is illustrated in FIG. 9B. Then, after stent portion 24 is deployed and balloon 46 is deflated (and thus radially retracted) sleeve 80 contracts about the distal end of balloon 46. The deflation of balloon 46 facilitates removal of balloon 46, as well as sleeve 80, from within the deployed stent portion 24, as deployment system 60 is axially removed from the vasculature. It should be noted that sleeves 80 and 82 can be used on substantially any of the embodiments described herein.
  • Thus, it can be seen that the present invention provides a system for deploying a stent at a bifurcation. The system includes a variety of dual-balloon delivery and deployment systems.
  • Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the scope of the invention as defined by the claims.

Claims (5)

  1. A dual balloon catheter (30) comprising:
    an elongate catheter body (32) having a distal end, at least one guide wire lumen (36, 38) therethrough and an inflation lumen (34) therein;
    a first proximal balloon (44) having a proximal portion (48) bonded to the catheter (32); and
    a second distal balloon (46) having a distal portion (56) bonded to the catheter distally of the first balloon, the proximal and distal balloons in fluid communication with the inflation lumen (34); characterised in that the catheter further comprises:
    a guide wire port positioned between the first and second balloons and in communication with the at least one guide wire lumen (36).
  2. The dual balloon catheter of claim 1 wherein a distal portion of the first balloon is bonded to a proximal portion of the second balloon.
  3. The dual balloon catheter of claim 1 or 2 further comprising:
    a second guide wire lumen (38) having a distal exit port distal of the distal portion of the second balloon.
  4. The dual balloon catheter of any one of the preceding claims further comprising:
    a distal waist means (50) on the first balloon configured to closely fit about a proximal waist (52) of the second balloon.
  5. The dual balloon catheter of any one of the preceding claims wherein the first balloon has a first axis offset from a second axis of the second balloon.
EP00905738A 1999-01-27 2000-01-26 Bifurcation stent delivery system Expired - Lifetime EP1152711B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05005600A EP1547546B1 (en) 1999-01-27 2000-01-26 Bifurcation stent delivery system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11735199P 1999-01-27 1999-01-27
US117351P 1999-01-27
PCT/US2000/001938 WO2000044307A1 (en) 1999-01-27 2000-01-26 Bifurcation stent delivery system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05005600A Division EP1547546B1 (en) 1999-01-27 2000-01-26 Bifurcation stent delivery system

Publications (2)

Publication Number Publication Date
EP1152711A1 EP1152711A1 (en) 2001-11-14
EP1152711B1 true EP1152711B1 (en) 2005-07-06

Family

ID=22372438

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00905738A Expired - Lifetime EP1152711B1 (en) 1999-01-27 2000-01-26 Bifurcation stent delivery system

Country Status (7)

Country Link
US (3) US7476243B2 (en)
EP (1) EP1152711B1 (en)
JP (1) JP2003525065A (en)
AT (1) ATE299001T1 (en)
CA (1) CA2360551C (en)
DE (2) DE60045193D1 (en)
WO (1) WO2000044307A1 (en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440165B1 (en) 1996-05-03 2002-08-27 Medinol, Ltd. Bifurcated stent with improved side branch aperture and method of making same
US6770092B2 (en) 1996-05-03 2004-08-03 Medinol Ltd. Method of delivering a bifurcated stent
US7238197B2 (en) * 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
US7686846B2 (en) 1996-06-06 2010-03-30 Devax, Inc. Bifurcation stent and method of positioning in a body lumen
JP2003525065A (en) * 1999-01-27 2003-08-26 ボストン サイエンティフィック リミテッド Bifurcation stent delivery system
EP1201203A1 (en) * 2000-10-26 2002-05-02 Jostra AG Device for exploration of branched vessels
US20060149587A1 (en) * 2001-11-26 2006-07-06 Pdx, Inc. Automated system and method for processing prescriptions
EP1369097A1 (en) * 2002-06-07 2003-12-10 CathNet-Science Holding A/S Balloon catheter assembly
WO2004041126A1 (en) 2002-11-08 2004-05-21 Jacques Seguin Endoprosthesis for vascular bifurcation
US7367989B2 (en) * 2003-02-27 2008-05-06 Scimed Life Systems, Inc. Rotating balloon expandable sheath bifurcation delivery
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US7731747B2 (en) 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7972372B2 (en) 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US7758630B2 (en) 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US7604621B2 (en) 2003-07-30 2009-10-20 Boston Scientific Scimed, Inc. Bifurcated stent delivery system
US7713296B2 (en) * 2003-10-16 2010-05-11 Minavasys, Sa Catheter system for stenting bifurcated vessels
US7641684B2 (en) * 2003-10-16 2010-01-05 Minvasys, Sa Catheter system for stenting bifurcated vessels
US7922753B2 (en) * 2004-01-13 2011-04-12 Boston Scientific Scimed, Inc. Bifurcated stent delivery system
DE602005021473D1 (en) * 2004-03-31 2010-07-08 Wilson Cook Medical Inc stent delivery system
AU2005232545B2 (en) * 2004-03-31 2010-08-12 Cook Medical Technologies Llc Stent deployment device
US7871431B2 (en) 2004-07-27 2011-01-18 The Cleveland Clinic Foundation Apparatus for treating atherosclerosis
US20060064064A1 (en) * 2004-09-17 2006-03-23 Jang G D Two-step/dual-diameter balloon angioplasty catheter for bifurcation and side-branch vascular anatomy
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US20060155356A1 (en) * 2005-01-13 2006-07-13 Israel Henry M Balloon catheter
US7850645B2 (en) * 2005-02-11 2010-12-14 Boston Scientific Scimed, Inc. Internal medical devices for delivery of therapeutic agent in conjunction with a source of electrical power
US8353944B2 (en) * 2005-03-14 2013-01-15 Boston Scientific Scimed, Inc. Bifurcation delivery system
US9034025B2 (en) 2005-05-23 2015-05-19 Ostial Corporation Balloon catheters and methods for use
US7862601B2 (en) * 2005-05-23 2011-01-04 Incept Llc Apparatus and methods for delivering a stent into an ostium
WO2007002423A2 (en) * 2005-06-24 2007-01-04 Abbott Laboratories Balloon catheter
US7582111B2 (en) 2005-08-22 2009-09-01 Incept, Llc Steep-taper flared stents and apparatus and methods for delivering them
US7766893B2 (en) * 2005-12-07 2010-08-03 Boston Scientific Scimed, Inc. Tapered multi-chamber balloon
US8197536B2 (en) 2006-03-10 2012-06-12 Cordis Corporation Method for placing a medical device at a bifurcated conduit
US7537608B2 (en) * 2006-05-23 2009-05-26 Boston Scientific Scimed, Inc. Stent with variable crimping diameter
EP2059291B1 (en) * 2006-08-23 2017-04-05 Abbott Laboratories Catheter system for delivering medical devices
US8216267B2 (en) 2006-09-12 2012-07-10 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
JP4562197B2 (en) * 2006-09-29 2010-10-13 朝日インテック株式会社 Balloon catheter assembly
US8414611B2 (en) * 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Main vessel constraining side-branch access balloon
US8398695B2 (en) 2006-11-03 2013-03-19 Boston Scientific Scimed, Inc. Side branch stenting system using a main vessel constraining side branch access balloon and side branching stent
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
CN101917929A (en) 2007-10-04 2010-12-15 特里瓦斯库拉尔公司 Modular vascular graft for low profile percutaneous delivery
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
WO2009088953A2 (en) * 2007-12-31 2009-07-16 Boston Scientific Scimed Inc. Bifurcation stent delivery system and methods
US20090287148A1 (en) * 2008-05-15 2009-11-19 Martin Daryl L Joined Inflation Portions for Bifurcation Catheter
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8377108B2 (en) * 2008-06-02 2013-02-19 Boston Scientific Scimed, Inc. Staggered two balloon bifurcation catheter assembly and methods
US20100016937A1 (en) * 2008-07-18 2010-01-21 Yousef Alkhatib Twisting Bifurcation Delivery System
US20100030192A1 (en) * 2008-08-01 2010-02-04 Boston Scientific Scimed, Inc. Catheter shaft bond arrangements and methods
US8715331B2 (en) * 2008-08-06 2014-05-06 Boston Scientific Scimed, Inc. Stent edge protection and methods
US8382818B2 (en) 2009-07-02 2013-02-26 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
DE102009047925A1 (en) * 2009-10-01 2011-06-16 Qualimed Innovative Medizinprodukte Gmbh Endoluminal tubular stent graft
EP2642946B1 (en) 2010-11-24 2023-08-16 Poseidon Medical Inc. Support for treating vascular bifurcations
CA2826769A1 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation with a fully crimped stent
EP2510972B1 (en) * 2011-04-14 2014-08-06 Biotronik AG Catheter device
EP2601995B1 (en) 2011-12-07 2022-08-17 CAR Holding B.V. An arrangement for implementing kissing balloons for simulating a bifurcated vessel, a kit, a method of manufacturing the arrangement and a catheter provided with a buffer volume.
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US10500077B2 (en) 2012-04-26 2019-12-10 Poseidon Medical Inc. Support for treating vascular bifurcations
US9233015B2 (en) 2012-06-15 2016-01-12 Trivascular, Inc. Endovascular delivery system with an improved radiopaque marker scheme
DE102015121545B4 (en) * 2015-12-10 2023-03-30 Acandis Gmbh catheter system
DE102015122677B4 (en) * 2015-12-23 2023-10-26 Acandis Gmbh Medical implant and set comprising an implant and a catheter system
KR101776043B1 (en) 2016-03-18 2017-09-07 연세대학교 산학협력단 Carinal anchoring double lumen tube
US11793658B2 (en) 2017-03-10 2023-10-24 The Cleveland Clinic Foundation Method and apparatuses for deploying an implant
US10350395B2 (en) * 2017-06-23 2019-07-16 Cook Medical Technologies Llc Introducer for lumen support or dilation
EP3858298B1 (en) 2020-01-31 2024-02-28 Bentley InnoMed GmbH Bifurcated balloon expandable stent assembly
US11324583B1 (en) 2021-07-06 2022-05-10 Archo Medical LTDA Multi-lumen stent-graft and related surgical methods

Family Cites Families (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US586777A (en) * 1897-07-20 Taege g
US3884242A (en) * 1971-03-29 1975-05-20 Mpc Kurgisil Catheter assembly
US4309994A (en) * 1980-02-25 1982-01-12 Grunwald Ronald P Cardiovascular cannula
US4774949A (en) * 1983-06-14 1988-10-04 Fogarty Thomas J Deflector guiding catheter
US4696668A (en) * 1985-07-17 1987-09-29 Wilcox Gilbert M Double balloon nasobiliary occlusion catheter for treating gallstones and method of using the same
US4921483A (en) * 1985-12-19 1990-05-01 Leocor, Inc. Angioplasty catheter
US5002532A (en) * 1987-01-06 1991-03-26 Advanced Cardiovascular Systems, Inc. Tandem balloon dilatation catheter
US4958634A (en) * 1987-05-06 1990-09-25 Jang G David Limacon geometry balloon angioplasty catheter systems and method of making same
DE8717643U1 (en) * 1987-05-12 1989-09-21 Domschke, Wolfram, Prof. Dr.med., 8520 Erlangen Device for endoscopic-transpapillary probing of a bile duct system
US4896670A (en) * 1988-04-19 1990-01-30 C. R. Bard, Inc. Kissing balloon catheter
US4998923A (en) * 1988-08-11 1991-03-12 Advanced Cardiovascular Systems, Inc. Steerable dilatation catheter
CH676426A5 (en) * 1988-09-27 1991-01-31 Schneider Shiley Ag
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US5147377A (en) * 1988-11-23 1992-09-15 Harvinder Sahota Balloon catheters
US5032113A (en) * 1989-04-13 1991-07-16 Scimed Life Systems, Inc. Innerless catheter
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5578071A (en) * 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
ES2071279T3 (en) * 1990-10-04 1995-06-16 Schneider Europ Ag EXPANSION BALL CATHETER.
CA2060067A1 (en) * 1991-01-28 1992-07-29 Lilip Lau Stent delivery system
WO1992014508A1 (en) 1991-02-15 1992-09-03 Mallinckrodt Medical, Inc. Torsionally stable guidewire
CA2069052A1 (en) 1991-05-21 1992-11-22 L. Venkata Raman Superelastic formable guidewire
WO1993004722A2 (en) 1991-09-05 1993-03-18 Mayo Foundation For Medical Education And Research Flexible tubular device for use in medical applications
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
JPH06182935A (en) * 1992-12-18 1994-07-05 Bridgestone Corp Gas barrier rubber laminate and manufacture thereof
US5487730A (en) * 1992-12-30 1996-01-30 Medtronic, Inc. Balloon catheter with balloon surface retention means
US5320605A (en) * 1993-01-22 1994-06-14 Harvinder Sahota Multi-wire multi-balloon catheter
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5607444A (en) * 1993-12-02 1997-03-04 Advanced Cardiovascular Systems, Inc. Ostial stent for bifurcations
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5636641A (en) * 1994-07-25 1997-06-10 Advanced Cardiovascular Systems, Inc. High strength member for intracorporeal use
US5609605A (en) * 1994-08-25 1997-03-11 Ethicon, Inc. Combination arterial stent
US5613980A (en) * 1994-12-22 1997-03-25 Chauhan; Tusharsindhu C. Bifurcated catheter system and method
NL9500094A (en) * 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
FR2733682B1 (en) * 1995-05-04 1997-10-31 Dibie Alain ENDOPROSTHESIS FOR THE TREATMENT OF STENOSIS ON BIFURCATIONS OF BLOOD VESSELS AND LAYING EQUIPMENT THEREFOR
AU5675196A (en) * 1995-06-08 1997-01-09 Bard Galway Limited Endovascular stent
US5556382A (en) * 1995-08-29 1996-09-17 Scimed Life Systems, Inc. Balloon perfusion catheter
US5669924A (en) * 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
FR2740346A1 (en) * 1995-10-30 1997-04-30 Debiotech Sa ANGIOPLASTY DEVICE FOR ARTERIAL BIFURCATION
US5632762A (en) * 1995-11-09 1997-05-27 Hemodynamics, Inc. Ostial stent balloon
US6436104B2 (en) * 1996-01-26 2002-08-20 Cordis Corporation Bifurcated axially flexible stent
US5824042A (en) * 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US6770092B2 (en) * 1996-05-03 2004-08-03 Medinol Ltd. Method of delivering a bifurcated stent
US6251133B1 (en) * 1996-05-03 2001-06-26 Medinol Ltd. Bifurcated stent with improved side branch aperture and method of making same
UA58485C2 (en) * 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
US5617878A (en) * 1996-05-31 1997-04-08 Taheri; Syde A. Stent and method for treatment of aortic occlusive disease
US6056775A (en) * 1996-05-31 2000-05-02 Ave Galway Limited Bifurcated endovascular stents and method and apparatus for their placement
US8728143B2 (en) * 1996-06-06 2014-05-20 Biosensors International Group, Ltd. Endoprosthesis deployment system for treating vascular bifurcations
US7238197B2 (en) * 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
FR2749500B1 (en) * 1996-06-06 1998-11-20 Jacques Seguin DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION
US5697971A (en) * 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5775734A (en) * 1996-08-02 1998-07-07 George, Jr.; Ralph N. Investment administration system
US5968068A (en) * 1996-09-12 1999-10-19 Baxter International Inc. Endovascular delivery system
US5749825A (en) * 1996-09-18 1998-05-12 Isostent, Inc. Means method for treatment of stenosed arterial bifurcations
US6692483B2 (en) * 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US6325826B1 (en) * 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6835203B1 (en) * 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6596020B2 (en) * 1996-11-04 2003-07-22 Advanced Stent Technologies, Inc. Method of delivering a stent with a side opening
AU4896797A (en) * 1996-11-04 1998-05-29 Davidson, Charles Extendible stent apparatus and method for deploying the same
US6599316B2 (en) * 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
EP0879473A1 (en) 1996-11-25 1998-11-25 Robertshaw Controls Company Voltage sensitive energy regulator using parallel control
US5720735A (en) * 1997-02-12 1998-02-24 Dorros; Gerald Bifurcated endovascular catheter
WO1998036709A1 (en) 1997-02-25 1998-08-27 Scimed Life Systems, Inc. Stents and stent delivery and dilatation system for bifurcation lesions
US6096073A (en) * 1997-02-25 2000-08-01 Scimed Life Systems, Inc. Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel
US20020133222A1 (en) * 1997-03-05 2002-09-19 Das Gladwin S. Expandable stent having a plurality of interconnected expansion modules
US6013054A (en) * 1997-04-28 2000-01-11 Advanced Cardiovascular Systems, Inc. Multifurcated balloon catheter
US5810871A (en) * 1997-04-29 1998-09-22 Medtronic, Inc. Stent delivery system
DE29708803U1 (en) 1997-05-17 1997-07-31 Jomed Implantate GmbH, 72414 Rangendingen Radially expandable stent for implantation in a body vessel in the area of a vascular branch
CA2424551A1 (en) * 1997-05-27 1998-11-27 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
US6258534B1 (en) * 1998-03-02 2001-07-10 Bbi Bioseq, Inc. Pressure-controlled nucleic acid hybridization
US6221090B1 (en) * 1997-08-13 2001-04-24 Advanced Cardiovascular Systems, Inc. Stent delivery assembly
US6165195A (en) * 1997-08-13 2000-12-26 Advanced Cardiovascylar Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6361544B1 (en) * 1997-08-13 2002-03-26 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6520988B1 (en) * 1997-09-24 2003-02-18 Medtronic Ave, Inc. Endolumenal prosthesis and method of use in bifurcation regions of body lumens
US6086611A (en) * 1997-09-25 2000-07-11 Ave Connaught Bifurcated stent
US6047363A (en) * 1997-10-14 2000-04-04 Advanced Micro Devices, Inc. Prefetching data using profile of cache misses from earlier code executions
US5893887A (en) * 1997-10-14 1999-04-13 Iowa-India Investments Company Limited Stent for positioning at junction of bifurcated blood vessel and method of making
US6033435A (en) * 1997-11-03 2000-03-07 Divysio Solutions Ulc Bifurcated stent and method for the manufacture and delivery of same
AU1170199A (en) 1997-11-07 1999-05-31 Ave Connaught Balloon catheter for repairing bifurcated vessels
US6030414A (en) * 1997-11-13 2000-02-29 Taheri; Syde A. Variable stent and method for treatment of arterial disease
US6395018B1 (en) * 1998-02-09 2002-05-28 Wilfrido R. Castaneda Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels
ATE313304T1 (en) * 1998-02-12 2006-01-15 Thomas R Marotta ENDOVASCULAR PROSTHESIS
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6099497A (en) 1998-03-05 2000-08-08 Scimed Life Systems, Inc. Dilatation and stent delivery system for bifurcation lesions
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6209673B1 (en) * 1998-05-22 2001-04-03 Gkn Automotive, Inc. All wheel drive system for a motor vehicle
US6168621B1 (en) * 1998-05-29 2001-01-02 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6143002A (en) * 1998-08-04 2000-11-07 Scimed Life Systems, Inc. System for delivering stents to bifurcation lesions
US6117117A (en) * 1998-08-24 2000-09-12 Advanced Cardiovascular Systems, Inc. Bifurcated catheter assembly
US6514281B1 (en) * 1998-09-04 2003-02-04 Scimed Life Systems, Inc. System for delivering bifurcation stents
US6017324A (en) * 1998-10-20 2000-01-25 Tu; Lily Chen Dilatation catheter having a bifurcated balloon
US6059824A (en) * 1998-12-23 2000-05-09 Taheri; Syde A. Mated main and collateral stent and method for treatment of arterial disease
US20050060027A1 (en) * 1999-01-13 2005-03-17 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US7655030B2 (en) * 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
JP2002534208A (en) * 1999-01-15 2002-10-15 ベントリカ, インコーポレイテッド Methods and devices for forming a vascular anastomosis
JP2003525065A (en) * 1999-01-27 2003-08-26 ボストン サイエンティフィック リミテッド Bifurcation stent delivery system
US6258099B1 (en) * 1999-03-31 2001-07-10 Scimed Life Systems, Inc. Stent security balloon/balloon catheter
US6319275B1 (en) * 1999-04-07 2001-11-20 Medtronic Ave, Inc. Endolumenal prosthesis delivery assembly and method of use
US6884258B2 (en) * 1999-06-04 2005-04-26 Advanced Stent Technologies, Inc. Bifurcation lesion stent delivery using multiple guidewires
US6440161B1 (en) * 1999-07-07 2002-08-27 Endologix, Inc. Dual wire placement catheter
DE19938377A1 (en) * 1999-08-06 2001-03-01 Biotronik Mess & Therapieg Stent for vascular branching
US6689156B1 (en) * 1999-09-23 2004-02-10 Advanced Stent Technologies, Inc. Stent range transducers and methods of use
US6210431B1 (en) * 1999-12-10 2001-04-03 John A. Power Ostial bifurcation lesion stenting catheter
US6254593B1 (en) * 1999-12-10 2001-07-03 Advanced Cardiovascular Systems, Inc. Bifurcated stent delivery system having retractable sheath
US6210433B1 (en) * 2000-03-17 2001-04-03 LARRé JORGE CASADO Stent for treatment of lesions of bifurcated vessels
US6334864B1 (en) * 2000-05-17 2002-01-01 Aga Medical Corp. Alignment member for delivering a non-symmetric device with a predefined orientation
US6482211B1 (en) * 2000-07-31 2002-11-19 Advanced Cardiovascular Systems, Inc. Angulated stent delivery system and method of use
US6475166B1 (en) * 2000-08-18 2002-11-05 Endovascular Technologies, Inc. Guidewire placement system for delivery of an aneurysm graft limb
GB0024625D0 (en) * 2000-10-07 2000-11-22 Pierce David B Tube finning machine
AU2001296716A1 (en) * 2000-10-13 2002-04-22 Rex Medical, Lp Covered stents with side branch
US6582394B1 (en) * 2000-11-14 2003-06-24 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcated vessels
US20030097169A1 (en) * 2001-02-26 2003-05-22 Brucker Gregory G. Bifurcated stent and delivery system
US6695877B2 (en) * 2001-02-26 2004-02-24 Scimed Life Systems Bifurcated stent
US6749628B1 (en) * 2001-05-17 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6743259B2 (en) * 2001-08-03 2004-06-01 Core Medical, Inc. Lung assist apparatus and methods for use
ATE413854T1 (en) * 2001-08-23 2008-11-15 Darrell C Gumm ROTATING STENT DELIVERY SYSTEM FOR DELIVERY INTO A SIDE BRANCH AND PROTECTION
US7252679B2 (en) * 2001-09-13 2007-08-07 Cordis Corporation Stent with angulated struts
US7004963B2 (en) * 2001-09-14 2006-02-28 Scimed Life Systems, Inc. Conformable balloons
US20040117003A1 (en) * 2002-05-28 2004-06-17 The Cleveland Clinic Foundation Minimally invasive treatment system for aortic aneurysms
US6858038B2 (en) * 2002-06-21 2005-02-22 Richard R. Heuser Stent system
US20040059406A1 (en) * 2002-09-20 2004-03-25 Cully Edward H. Medical device amenable to fenestration
US7326242B2 (en) * 2002-11-05 2008-02-05 Boston Scientific Scimed, Inc. Asymmetric bifurcated crown
US8298280B2 (en) * 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US8808351B2 (en) * 2003-10-10 2014-08-19 Cook Medical Technologies Llc Stretchable prosthesis fenestration
US20050131526A1 (en) * 2003-12-10 2005-06-16 Shing-Chiu Wong Stent and balloon system for bifurcated vessels and lesions
EP1753369B1 (en) * 2004-06-08 2013-05-29 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
US20060041303A1 (en) * 2004-08-18 2006-02-23 Israel Henry M Guidewire with stopper
JP5207737B2 (en) * 2004-09-15 2013-06-12 イノヴェイショナル・ホールディングズ・エルエルシー Bifurcated stent with collapsible end
US20060064064A1 (en) * 2004-09-17 2006-03-23 Jang G D Two-step/dual-diameter balloon angioplasty catheter for bifurcation and side-branch vascular anatomy
US7582111B2 (en) * 2005-08-22 2009-09-01 Incept, Llc Steep-taper flared stents and apparatus and methods for delivering them

Also Published As

Publication number Publication date
US8398698B2 (en) 2013-03-19
JP2003525065A (en) 2003-08-26
DE60021173D1 (en) 2005-08-11
US7476243B2 (en) 2009-01-13
CA2360551A1 (en) 2000-08-03
US20050192656A1 (en) 2005-09-01
EP1152711A1 (en) 2001-11-14
DE60021173T2 (en) 2006-04-27
ATE299001T1 (en) 2005-07-15
US20090182406A1 (en) 2009-07-16
CA2360551C (en) 2009-12-22
US20070173920A1 (en) 2007-07-26
WO2000044307A1 (en) 2000-08-03
DE60045193D1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
EP1152711B1 (en) Bifurcation stent delivery system
CA2321040C (en) Dilatation and stent delivery system for bifurcation lesions
US6096073A (en) Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel
US6514281B1 (en) System for delivering bifurcation stents
US5810872A (en) Flexible stent
US20180085562A1 (en) Stiffened balloon apparatus
ES2662946T3 (en) Directional expansion of intraluminal devices
US6142973A (en) Balloon catheter for repairing bifurcated vessels
US7875071B2 (en) System and method for delivering a bifurcated stent
EP1011528A1 (en) Stents and stent delivery and dilatation system for bifurcation lesions
EP2147661A2 (en) Catheter Balloon System
EP0904745A2 (en) Endolumenal prosthesis and method of use in bifurcation regions of body lumens
EP3082661B1 (en) Balloon catheters and system
US20120089220A1 (en) Microcatheter
JPH10295825A (en) Supply device for medical system having compression area
EP1547546B1 (en) Bifurcation stent delivery system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010824

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20031008

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050706

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050706

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050706

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050706

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050706

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60021173

Country of ref document: DE

Date of ref document: 20050811

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051006

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051006

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051017

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051212

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060131

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060131

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20060407

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050706

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20101221

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20101215

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20110117

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20110221

Year of fee payment: 12

BERE Be: lapsed

Owner name: *BOSTON SCIENTIFIC LTD

Effective date: 20120131

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20120801

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20120126

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20120928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120131

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120801

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60021173

Country of ref document: DE

Representative=s name: VOSSIUS & PARTNER PATENTANWAELTE RECHTSANWAELT, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60021173

Country of ref document: DE

Representative=s name: VOSSIUS & PARTNER PATENTANWAELTE RECHTSANWAELT, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60021173

Country of ref document: DE

Representative=s name: VOSSIUS & PARTNER PATENTANWAELTE RECHTSANWAELT, DE

Effective date: 20150203

Ref country code: DE

Ref legal event code: R082

Ref document number: 60021173

Country of ref document: DE

Representative=s name: VOSSIUS & PARTNER PATENTANWAELTE RECHTSANWAELT, DE

Effective date: 20141026

Ref country code: DE

Ref legal event code: R081

Ref document number: 60021173

Country of ref document: DE

Owner name: BOSTON SCIENTIFIC LIMITED, BM

Free format text: FORMER OWNER: BOSTON SCIENTIFIC LTD., ST MICHAEL, BARBADOS, BB

Effective date: 20150203

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20150120

Year of fee payment: 16

Ref country code: IE

Payment date: 20150112

Year of fee payment: 16

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60021173

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160802

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160126